PhRMA: HHS Failed To Show It Consulted With USTR On Drug Import Rule

By John Wilkerson / June 14, 2022 at 5:16 PM
HHS failed to show that it consulted with the U.S. Trade Representative or the Commissioner of Customs and Border Protection before publishing a rule to allow Canadian drug imports, the Pharmaceutical Research and Manufacturers of America says in its most recent filing in its lawsuit against the drug import rule . The Trump administration wrote a few health care rules that ran into trouble for not going through the legally required process, and PhRMA now alleges the Trump administration also...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.